Drug Name:
CENTRUM OTC
Generic Name and Formulations:
Vit. A 5000Units (40% as beta carotene), thiamine 1.5mg, riboflavin 1.7mg, niacinamide 20mg, pantothenic acid 10mg, pyridoxine 2mg, Vit. B12 6mcg, biotin 30mcg, folic acid 0.4mg, Vit. C 60mg, Vit. D 400Units, Vit. E 30Units, Vit. K 25mcg, calcium (as phosphate and carbonate) 162mg, iron (as fumarate) 18mg, chloride (as potassium) 72mg, chromium (as Cl) 120mcg, copper (as oxide) 2mg, iodine (as potassium) 150mcg, magnesium (as oxide) 100mg, manganese 2mg, molybdenum 75mcg, nickel 5mcg, phosphorus (as calcium) 109mg, potassium (as Cl) 80mg, selenium 20mcg, silicon 2mg, vanadium 10mcg, tin 10mcg, zinc (as oxide) 15mg, boron 150mcg; tabs.
Company:
Pfizer Consumer Healthcare
Therapeutic Use:
Indications for CENTRUM:
Nutritional supplement.
Adult:
1 tab daily (w. food in GI upset).
Children:
Not recommended.
Contraindications:
Treatment of pernicious or other megaloblastic anemia. Wilson's disease. Hemochromatosis.
Warnings/Precautions:
Hypoparathyroidism. Folic acid may mask pernicious anemia.
Interactions:
Tetracycline absorption blocked by iron, calcium.
How Supplied:
Tabs—60, 180
Clinical Pain Advisor Articles
- Suprazygomatic Sphenopalatine Ganglion Block May Quickly Relieve Status Migrainosus Pain
- Reducing Mortality After Overdose: Is Treatment for Opioid Use Disorder Effective?
- Set of Personality Traits May Predict Prescription Drug Use, Misuse in Young Adults
- Low Literacy Self-Management Program for Chronic Pain May Be Effective
- Predicting Pain Chronicization After Spine Surgery
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- Reducing Mortality After Overdose: Is Treatment for Opioid Use Disorder Effective?
- Medicaid Expansion Under the ACA Increased Access to Opioid Use Disorder Treatments
- DEA Proposal Will Significantly Cut Opioid Manufacturing in 2019
- Survey Says: Perspectives From Women in Health Care
- Butalbital/APAP Capsules Launched for Complex Tension Headache
- Concomitant Use of Pregabalin and Opioids May Increase Risk for Opioid-Related Death
